FCGR1A

Fc Gamma Receptor Ia (CD64)

Gene Information Card

Symbol FCGR1A
Full Name Fc Gamma Receptor Ia
Gene Type protein-coding
Chromosomal Location 1q21.2
NCBI Gene ID 2209 ncbi.nlm.nih.gov/gene/2209
Ensembl ID ENSG00000150337
UniProt ID P12314
OMIM ID 146760
HGNC ID 3613
Aliases CD64, FcgammaRI, FcRI, IGFR1

Description

FCGR1A encodes the high-affinity Fc gamma receptor Ia (CD64), a transmembrane glycoprotein expressed on macrophages, monocytes, and activated neutrophils. It binds the Fc region of IgG with high affinity and mediates phagocytosis, antibody-dependent cellular cytotoxicity (ADCC), and cytokine release. FCGR1A plays a critical role in immune defense against pathogens and is implicated in autoimmune diseases and inflammatory disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Rheumatoid Arthritis FCGR1A overexpression on synovial macrophages enhances IgG immune complex uptake, driving pro-inflammatory cytokine release. ClinVar, OMIM
Systemic Lupus Erythematosus Increased FCGR1A expression on monocytes promotes clearance of IgG-containing immune complexes, contributing to tissue inflammation. ClinVar, OMIM
Infectious Diseases (e.g., tuberculosis) FCGR1A mediates phagocytosis of IgG-opsonized pathogens; polymorphisms may affect susceptibility. NCBI Gene, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Whole blood 12.5 High
Spleen 8.3 Medium
Lung 6.1 Medium
Bone marrow 5.4 Medium
Liver 2.1 Low
Cell Line Expression
Cell Line nTPM Notes
Monocytes (THP-1) 15.2 High expression; used in ADCC assays
Macrophages (differentiated) 18.7 High expression; key for phagocytosis
Neutrophils (activated) 9.8 Induced upon activation
B lymphocytes (Raji) 0.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.497A>G (p.Asn166Ser) missense <0.1% May alter IgG binding affinity; reported in autoimmune cohorts
c.1123G>A (p.Gly375Arg) missense <0.1% Potential impact on receptor dimerization
c.1-9C>T intronic 0.2% Associated with altered expression levels in monocytes
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in FCGR1A are rare; they impair IgG binding and phagocytosis, increasing susceptibility to bacterial infections.

Gain of Function (GOF)

Gain-of-function variants (e.g., promoter polymorphisms) increase receptor expression, linked to enhanced inflammatory responses in autoimmune diseases.

Dominant Negative (DN)

No dominant-negative mutations have been reported for FCGR1A.

Gene Ontology (GO)

• Fc-gamma receptor I complex • IgG binding
• phagocytosis • antibody-dependent cellular cytotoxicity
• signal transduction • cell surface receptor signaling pathway
• innate immune response • positive regulation of cytokine production

Pathways

Fc gamma receptor-mediated phagocytosis (KEGG: hsa04666)
Fc epsilon RI signaling pathway (KEGG: hsa04664)
Natural killer cell mediated cytotoxicity (KEGG: hsa04650)
Immune System (Reactome: R-HSA-168256)

Protein Summary

FCGR1A encodes the high-affinity Fc gamma receptor Ia (CD64), a 72 kDa transmembrane protein with three extracellular immunoglobulin-like domains. It binds monomeric IgG with high affinity (Ka ~10^8 M^-1) and is constitutively expressed on macrophages, monocytes, and activated neutrophils. Upon IgG binding, FCGR1A triggers ITAM-mediated signaling via the associated FcR gamma chain, leading to phagocytosis, ADCC, and pro-inflammatory cytokine release. CD64 is a key marker for monocyte/macrophage lineage and is upregulated in inflammatory conditions.

Related Products

Product name Cat.No. Species Gene ID
FCGR1A Knockout HEK293 Cell Line EDJ-KQ50267 Human 2209 Details Get a Quote
FCGR1A Knockout HeLa Cell Line EDJ-KQ53207 Human 2209 Details Get a Quote
FCGR1A Knockout A-549 Cell Line EDJ-KQ61688 Human 2209 Details Get a Quote
FCGR1A Knockout HCT 116 Cell Line EDJ-KQ70174 Human 2209 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: